Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

Phase 2

Conditions: Diabetes Mellitus, Type 2
Pre-diabetes

Interventions: Drug: 18F-MK6240 injection

First Posted Date: 2018-01-03

Last Posted Date: 2024-03-04

Lead Sponsor: Columbia University

Target Recruit Count: 600

Registration Number: NCT03389100

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Nutrition, Arsenic and Cognitive Function in Children

Not Applicable

Completed

Conditions: Arsenic Exposure

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Vitamin B12
Dietary Supplement: Folic Acid

First Posted Date: 2017-12-28

Last Posted Date: 2021-02-16

Lead Sponsor: Columbia University

Target Recruit Count: 239

Registration Number: NCT03384862

Locations: 🇧🇩
Columbia University Bangladesh, Dhaka, Bangladesh

Metabolism and Bariatric Surgery Study

Not Applicable

Active, not recruiting

Conditions: Insulin Resistance
Obesity

Interventions: Behavioral: Very Low Calorie Diet (VLCD)
Procedure: Roux-en-Y Gastric Bypass (RYGBP)
Procedure: Sleeve Gastrectomy (SG)

First Posted Date: 2017-12-13

Last Posted Date: 2024-04-02

Lead Sponsor: Columbia University

Target Recruit Count: 70

Registration Number: NCT03371368

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Rapid Assessment of Esophageal Adenocarcinoma Risk Test

Not Applicable

Terminated

Conditions: Esophageal Adenocarcinoma
Barrett Esophagus

Interventions: Device: Cytosponge

First Posted Date: 2017-12-08

Last Posted Date: 2024-11-08

Lead Sponsor: Columbia University

Target Recruit Count: 51

Registration Number: NCT03366012

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Primary Intensivists and Primary Nurses to Decrease Pediatric ICU Length of Stay

Not Applicable

Completed

Conditions: ICU Length of Stay

Interventions: Behavioral: Primary intensivist and nurses

First Posted Date: 2017-12-07

Last Posted Date: 2020-07-27

Lead Sponsor: Columbia University

Target Recruit Count: 200

Registration Number: NCT03364933

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Phase 4

Completed

Conditions: Breast Cancer Female

Interventions: Other: Placebo Drug
Drug: Bupivacaine Hydrochloride
Device: Pulsed Electromagnetic Field (PEMF) Device
Other: Placebo Device
Drug: Ropivacaine Hydrochloride

First Posted Date: 2017-12-04

Last Posted Date: 2022-03-09

Lead Sponsor: Columbia University

Target Recruit Count: 60

Registration Number: NCT03360214

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Predictors of Lorcaserin-Induced Weight Loss

Phase 4

Terminated

Conditions: Overweight and Obesity

Interventions: Drug: Belviq
Drug: Placebo

First Posted Date: 2017-11-27

Last Posted Date: 2024-03-27

Lead Sponsor: Columbia University

Target Recruit Count: 32

Registration Number: NCT03353220

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Encouraging LPG Adoption in Ghana: A Factorial Randomized Clinical Trial to Enhance LPG Adoption & Sustained Use

Not Applicable

Completed

Conditions: Health Attitude
Behavior, Consumer
Health Knowledge, Attitudes, Practice

Interventions: Other: Infrastructural Intervention - Direct Delivery
Behavioral: RANAS Behavior Change Intervention

First Posted Date: 2017-11-24

Last Posted Date: 2019-01-31

Lead Sponsor: Columbia University

Target Recruit Count: 781

Registration Number: NCT03352830

Locations: 🇬🇭
Kintampo Medical Research Center, Kintampo, Ghana
🇺🇸
Columbia University Medical Center, New York, New York, United States

Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in Botswana

Completed

Conditions: Drug Interaction
Contraceptive Usage
HIV Infections

Interventions: Drug: dolutegravir
Device: ENG implant
Drug: Efavirenz

First Posted Date: 2017-11-08

Last Posted Date: 2020-02-05

Lead Sponsor: Columbia University

Target Recruit Count: 148

Registration Number: NCT03336346

Locations: 🇧🇼
Botswana-UPenn Partnership, Gaborone, Botswana

Metformin in Heart Failure Without Diabetes

Phase 2

Terminated

Conditions: Heart Failure

Interventions: Drug: Placebo
Drug: Metformin hydrochloride

First Posted Date: 2017-11-06

Last Posted Date: 2024-07-18

Lead Sponsor: Columbia University

Target Recruit Count: 6

Registration Number: NCT03331861

Locations: 🇺🇸
New York Hospital - Columbia University Irving Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy